WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

SPECTRUM AND ASSOCIATED RISK FACTORS OF OPPORTUNISTIC INFECTIONS AMONG ANTIRETROVIRAL THERAPY EXPERIENCED HIV/AIDS PATIENTS IN ADDIS ABABA, ETHIOPIA.

Mebrahtu Eyasu*, Abreham Berhane, Semere Yohannes

 

ABSTRACT

Background: HIV/AIDS patients are developing opportunistic infections (OIs). Hence, this study aimed to determine the prevalence of OIs and associated risk factors (RFs) among HIV/AIDS patients receiving the first- and second-line antiretroviral drugs therapy. Methodology: Hospital based analytical cross-sectional study design was used to determine the prevalence of OIs and to identify associated risk factors for their occurrence in HIV/AIDS patients. For data collection, pre-tested structured questionnaire and chart review methods were applied. To determine the associated RFs for OIs, bivariate and multiple analysis logistic regression models were used. Data were analyzed by using SPSS version 20 statistical software. P-value ≤ 0.05 was considered statistically significant. Results: Out of 442 patients, the overall of prevalence of OIs was 183(41.4%). Candidiasis, bacterial pneumonia, and upper respiratory infections were predominant OIs identified with prevalence of (n= 43/442, 9.7%), (n=39/442, 8.8%), and (n=25/442, 5.7%), respectively. Clinical risk factors identified were: traditional medicine use (AOR (95% CI)=2.044(1.096-3.814), P=0.025); lack of knowledge on OIs (AOR (95% CI)= 1.783(1.014-3.134), P=0.045); WHO Stage (III-IV) (baseline) (AOR (95% CI) = 2.660(1.432-4.939), P=0.002); first-line current drug regimen (AOR (95% CI) =1.937(1.067-3.516), P=0.030); poor ARV adherence status (AOR (95% CI)= 4.088(1.041-16.053), P=0.044); current CD4+ <200 cells/μL (AOR (95% CI) = 2.166(1.001-4.690), P=0.050); no other drugs use(AOR (95% CI) = 5.932(2.335-15.071), P<0.001) and current Hgb level <10g/dl (AOR (95% CI) = 25.784(1.895-350.902, P=0.015). Conclusion: OIs still remain being challenges for the quality of ART services. Thus, organizations working on HIV/AIDS should work jointly to reduce OI related morbidity and mortality rate.

Keywords: Ethiopia, first-line ARV drugs, HIV/AIDS, Opportunistic infections, second-line ARV drugs, co-trimoxazole.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More